Bio-Rad Laboratories

The Florida Department of Health, Bureau of Public Health Laboratories (BPHL), is seeking to purchase a FDA-approved confirmatory assay system to perform HIV-1/HIV-2 Supplemental differentiation assay testing. The system must be able to test whole blood, serum, plasma, and in-house validated oral fluid to conform to the CDC 2014 HIV Diagnostic Algorithm guidelines. The Bio-Rad Laboratories Geenius™ System assays and controls are the only FDA-approved HIV-1/HIV-2 differential assay currently on the U.S. market and have been validated in-house for the confirmation of HIV-1 Oral Fluid meeting the guidelines required. The contract is for a 3-year term. Key aspects of the job include: • Performing HIV-1/HIV-2 Supplemental differentiation assay testing • Testing whole blood, serum, plasma, and in-house validated oral fluid • Conforming to the CDC 2014 HIV Diagnostic Algorithm guidelines • Using the Bio-Rad Laboratories Geenius™ System assays and controls • 3-year contract term